Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experience.
Copete M, Garratt J, Gilks B, Pilavdzic D, Berendt R, Bigras G, Mitchell S, Lining LA, Cheung C, Torlakovic EE. Copete M, et al. Among authors: garratt j. J Clin Pathol. 2011 Mar;64(3):220-5. doi: 10.1136/jcp.2010.085258. Epub 2011 Jan 22. J Clin Pathol. 2011. PMID: 21258091
The laboratory score/reference method score ratio (LSRSR) is a novel tool for monitoring laboratory performance in immunohistochemistry proficiency testing of hormone receptors in breast cancer: the CIQC experience.
Cheung CC, Neufeld H, Lining LA, Pilavdzic D, Copete M, Garratt J, Gilks B, Torlakovic EE. Cheung CC, et al. Among authors: garratt j. Am J Clin Pathol. 2011 Jul;136(1):67-73. doi: 10.1309/AJCPQ6I9GHJMCBEV. Am J Clin Pathol. 2011. PMID: 21685033
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
Terry J, Torlakovic EE, Garratt J, Miller D, Köbel M, Cooper J, Bahzad S, Pilavdzic D, O'Malley F, O'Brien AE, SenGupta S, Alport E, Têtu B, Knight B, Pettigrew NM, Berendt R, Wolber R, Trotter MJ, Riddell RH, Gaboury L, Elms F, Magliocco A, Barnes P, Gown AM, Gilks CB. Terry J, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):375-82. doi: 10.1097/PAI.0b013e31819adacf. Appl Immunohistochem Mol Morphol. 2009. PMID: 19363444
Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.
Makretsov N, Gilks CB, Alaghehbandan R, Garratt J, Quenneville L, Mercer J, Palavdzic D, Torlakovic EE; Canadian Immunohistochemistry Quality Control Program; Canadian Association of Pathologists. Makretsov N, et al. Among authors: garratt j. Arch Pathol Lab Med. 2011 Jul;135(7):874-81. doi: 10.5858/2010-0380-OAR1.1. Arch Pathol Lab Med. 2011. PMID: 21732777 Free article.
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry.
Cheung CC, Banerjee D, Barnes PJ, Berendt RC, Butany J, Canil S, Clarke BA, El-Zimaity H, Garratt J, Geldenhuys L, Gilks CB, Manning L, Mengel M, Perez-Ordonez B, Pilavdzic D, Riddell R, Swanson PE, Torlakovic EE. Cheung CC, et al. Among authors: garratt j. Am J Clin Pathol. 2014 Nov;142(5):629-33. doi: 10.1309/AJCP77GXYVEQXMXT. Am J Clin Pathol. 2014. PMID: 25319977
Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.
Cheung CC, Garratt J, Won J, Cutz JC, Gilks BC, Tsao M, Torlakovic EE. Cheung CC, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):677-81. doi: 10.1097/PAI.0000000000000267. Appl Immunohistochem Mol Morphol. 2015. PMID: 26551338 Clinical Trial.
Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing.
Cheung CC, Lim HJ, Garratt J, Won J, Gilks CB, Torlakovic EE. Cheung CC, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):251-257. doi: 10.1097/PAI.0000000000000734. Appl Immunohistochem Mol Morphol. 2019. PMID: 30789848 Clinical Trial.
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.
Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu EB, Swanson PE, Taylor CR, Vyberg M; International Ad Hoc Expert Panel. Torlakovic EE, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):241-52. doi: 10.1097/PAI.0000000000000069. Appl Immunohistochem Mol Morphol. 2014. PMID: 24714041 Free PMC article.
54 results